Concepedia
Statistics
Publications
25
Citations
1.8K
H-Index
22
Active since
2013
Affiliations
Emory University(Current)
The Ohio State University
Piedmont Cancer Institute
Roswell Park Comprehensive Cancer Center
The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute
Matthew R. Farren is an author at Emory University specializing in oncology, medicine, and immunology.
Publications per year
2013–2025
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis
Jeremy D. Waight, Colleen S. Netherby, Mary L. Hensen et al. · Journal of Clinical Investigation · 2013 · 319 citations · Full text
Medicine, Immunology, Oncology +16
Lipocalin-2 Promotes Pancreatic Ductal Adenocarcinoma by Regulating Inflammation in the Tumor Microenvironment
Sobeyda B. Gomez-Chou, Agnieszka Świdnicka‐Siergiejko, Niharika Badi et al. · Cancer Research · 2017 · 171 citations · Full text
Medicine, Cancer Biology, Oncology +17
Randomized Phase 2 Trial of the Oncolytic Virus Pelareorep (Reolysin) in Upfront Treatment of Metastatic Pancreatic Adenocarcinoma
Anne M. Noonan, Matthew R. Farren, Susan Geyer et al. · Molecular Therapy · 2016 · 161 citations · Full text
Medicine, Oncology, Pharmacology +17
Tumor Stromal Architecture Can Define the Intrinsic Tumor Response to VEGF-Targeted Therapy
Neil R. Smith, Dawn Baker, Matthew R. Farren et al. · Clinical Cancer Research · 2013 · 136 citations · Full text
Systemic Immune Activity Predicts Overall Survival in Treatment-Naïve Patients with Metastatic Pancreatic Cancer
Matthew R. Farren, Thomas A. Mace, Susan Geyer et al. · Clinical Cancer Research · 2015 · 110 citations · Full text
Medicine, Immunology, Oncology +17
1–5 of 25